$BIIB

Christopher A. Viehbacher

Biogen

President & CEO • Since 2022 • Health Care

📊 CEO Reputation Score

FY2025 vs FY2024 · Source: SEC EDGAR filings

18/100

Blend of this company's year-over-year free-cash-flow and profit improvement, each ranked as a percentile against every scored company in the three indexes.

Free cash flow: $2.7B → $2.1B (−24.7% YoY) — fiscal 2025 vs fiscal 2024
Profit (net income): $1.6B → $1.3B (−20.8% YoY) — fiscal 2025 vs fiscal 2024

How this score works · S&P 500 reputation leaderboard

Overview

Christopher A. Viehbacher is the president & ceo of Biogen since 2022. Biogen is a Health Care company headquartered in Cambridge, Massachusetts, founded in 1978, and one of the 500 companies in the S&P 500 — every one of which is profiled on this site.

Leadership

Christopher holds the chief executive role at Biogen with the title President & CEO — in post since 2022. This page is the concise leadership record for Biogen in the S&P 500 CEO index; the site's fully researched long-form profiles (career timelines, education, achievements, setbacks, philosophy and sourced quotes) currently cover the index's ten largest companies, and this entry will be expanded in the same format.

At a Glance

Sector: Health Care
Ticker: $BIIB
Headquarters: Cambridge, Massachusetts
Founded: 1978
CEO since: 2022
Index: S&P 500 (#63 of 500)